Versant Ventures V, Llc - Net Worth and Insider Trading
Versant Ventures V, Llc Net Worth
The estimated net worth of Versant Ventures V, Llc is at least $23 Million dollars as of 2024-05-11. Versant Ventures V, Llc is the 10% Owner of Repare Therapeutics Inc and owns about 3,544,862 shares of Repare Therapeutics Inc (RPTX) stock worth over $12 Million. Versant Ventures V, Llc is also the 10% Owner of Turnstone Biologics Corp and owns about 3,381,692 shares of Turnstone Biologics Corp (TSBX) stock worth over $10 Million. Details can be seen in Versant Ventures V, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Versant Ventures V, Llc has not made any transactions after 2023-07-25 and currently still holds the listed stock(s).
Transaction Summary of Versant Ventures V, Llc
Versant Ventures V, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Versant Ventures V, Llc owns 5 companies in total, including Repare Therapeutics Inc (RPTX) , Aprea Therapeutics Inc (APRE) , and Crinetics Pharmaceuticals Inc (CRNX) among others .
Click here to see the complete history of Versant Ventures V, Llc’s form 4 insider trades.
Insider Ownership Summary of Versant Ventures V, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RPTX | Repare Therapeutics Inc | 2022-06-03 | 10 percent owner |
| APRE | Aprea Therapeutics Inc | 2020-04-09 | 10 percent owner |
| CRNX | Crinetics Pharmaceuticals Inc | 2019-02-04 | 10 percent owner |
 | | 2018-04-24 | 10 percent owner |
| | 2023-07-25 | 10 percent owner |
Versant Ventures V, Llc Latest Holdings Summary
Versant Ventures V, Llc currently owns a total of 2 stocks. Among these stocks, Versant Ventures V, Llc owns 3,544,862 shares of Repare Therapeutics Inc (RPTX) as of June 3, 2022, with a value of $12 Million and a weighting of 54.61%. Versant Ventures V, Llc also owns 3,381,692 shares of Turnstone Biologics Corp (TSBX) as of July 25, 2023, with a value of $10 Million and a weighting of 45.39%.
Latest Holdings of Versant Ventures V, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPTX | Repare Therapeutics Inc | 2022-06-03 | 3,544,862 | 3.50 | 12,407,017 |
| TSBX | Turnstone Biologics Corp | 2023-07-25 | 3,381,692 | 3.05 | 10,314,161 |
Holding Weightings of Versant Ventures V, Llc
Versant Ventures V, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Versant Ventures V, Llc has made a total of 2 transactions in Repare Therapeutics Inc (RPTX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Repare Therapeutics Inc is the sale of 750,000 shares on June 3, 2022, which brought Versant Ventures V, Llc around $9 Million.
According to the SEC Form 4 filings, Versant Ventures V, Llc has made a total of 1 transactions in Turnstone Biologics Corp (TSBX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Turnstone Biologics Corp is the acquisition of 225,000 shares on July 25, 2023, which cost Versant Ventures V, Llc around $3 Million.
Insider Trading History of Versant Ventures V, Llc
- 1
Versant Ventures V, Llc Trading Performance
GuruFocus tracks the stock performance after each of Versant Ventures V, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Versant Ventures V, Llc is -39.97%. GuruFocus also compares Versant Ventures V, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Versant Ventures V, Llc within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Versant Ventures V, Llc's insider trading performs compared to the benchmark.
Performance of Versant Ventures V, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.22 | | | | | |
| Relative Return to S&P 500(%) | -18.12 | | | | | |
Versant Ventures V, Llc Ownership Network
Versant Ventures V, Llc Owned Company Details
What does Repare Therapeutics Inc do?
Who are the key executives at Repare Therapeutics Inc?
Versant Ventures V, Llc is the 10 percent owner of Repare Therapeutics Inc. Other key executives at Repare Therapeutics Inc include EVP & Chief Medical Officer Maria Koehler , EVP & Chief Science Officer Michael Zinda , and EVP & Chief Financial Officer Steve Forte .
Repare Therapeutics Inc (RPTX) Insider Trades Summary
Over the past 18 months, Versant Ventures V, Llc made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .
In summary, during the past 3 months, insiders sold 21,690 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 21,690 shares. During the past 18 months, 282,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,728,847 shares.
Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Repare Therapeutics Inc Insider Transactions
Versant Ventures V, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Versant Ventures V, Llc. You might contact Versant Ventures V, Llc via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
